Hidden Muscle Fat Linked to Heart Disease

What Is Intermuscular Fat and Why Does It Matter?

Intermuscular adipose tissue (IMAT), sometimes referred to as myosteatosis when it infiltrates muscle fibers, is a form of ectopic fat that builds up alongside skeletal muscle. Unlike subcutaneous fat under the skin or even visceral fat around internal organs, IMAT is largely invisible from the outside and undetectable by standard scales or BMI measurements. A person with a normal weight can still carry substantial intermuscular fat, a condition sometimes described as being metabolically obese despite normal weight.

This hidden fat is biologically active. It releases inflammatory cytokines and free fatty acids directly into nearby muscle, impairing the muscle's ability to take up glucose in response to insulin. Over time, this contributes to insulin resistance, a precursor to type 2 diabetes, and is increasingly recognized as a contributor to cardiovascular disease. Researchers have long suspected that muscle quality, not just muscle quantity, plays a major role in metabolic health, but quantifying it required tedious manual analysis of imaging scans.

How Did Deep Learning Reveal the Risk?

The German research team applied a convolutional neural network to MRI scans, training it to distinguish lean muscle tissue from fat infiltration with high accuracy. By automating segmentation, the team could analyze thousands of scans far faster than manual radiology review allows, opening the door to large epidemiological studies of muscle composition. When they compared muscle composition to clinical data, a clear pattern emerged: individuals with higher proportions of intermuscular fat relative to lean muscle were more likely to have elevated blood pressure, abnormal glucose metabolism, and other markers of cardiometabolic disease.

The clinical implications are significant. Body mass index, the most widely used metric in primary care, cannot distinguish a muscular individual from someone whose mass comes from fat infiltrating their muscles. AI-augmented imaging may eventually allow clinicians to identify high-risk patients who appear healthy by conventional measures, enabling earlier lifestyle interventions or pharmacological treatment. It also reinforces a growing message in metabolic medicine: physical activity that builds and preserves lean muscle quality may be as important as weight loss itself.

Can Lifestyle Changes Reduce Intermuscular Fat?

Research over the past decade has consistently shown that intermuscular fat is responsive to exercise. Resistance training, in particular, appears to reduce fat infiltration while building lean mass, improving the ratio of healthy muscle to fat. Aerobic exercise contributes by increasing the muscles' oxidative capacity and improving insulin sensitivity. Combined approaches that include both modalities tend to produce the strongest improvements in muscle quality, especially in older adults at risk for sarcopenia, where age-related muscle loss is often accompanied by increased fat infiltration.

Dietary patterns also matter. Mediterranean-style diets rich in omega-3 fatty acids, fiber, and plant proteins have been associated with lower ectopic fat accumulation in observational studies, while diets high in ultra-processed foods correlate with the opposite. Newer pharmacological therapies, including GLP-1 receptor agonists, may also reduce ectopic fat depots, though preserving lean mass during weight loss remains a clinical concern. The takeaway for patients is encouraging: muscle composition is not fixed, and targeted lifestyle changes can meaningfully reduce hidden risk.